Thymectomy for myasthenia gravis: Evaluation requires controlled prospective studies

Annals of Thoracic Surgery

Volumn 76, Issue 1, 2003, Pages 1-3

  Jaretzki III, Alfred ^a   Aarli, Johan A ^a   Kaminski, Henry J ^a   Phillips II, Lawrence H ^a   Sanders, Donald B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE DISEASE; EDITORIAL; EVALUATION; FOLLOW UP; HUMAN; MYASTHENIA GRAVIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; SURGICAL TECHNIQUE; SURVIVAL RATE; THYMECTOMY; TREATMENT OUTCOME;

CONTROLLED CLINICAL TRIALS; EVALUATION STUDIES; FEMALE; HUMANS; MALE; MYASTHENIA GRAVIS; PROGNOSIS; PROSPECTIVE STUDIES; RESEARCH DESIGN; THYMECTOMY; TREATMENT OUTCOME;

EID: 0037662276     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(03)00488-0     Document Type: Editorial

References (24)

1. Jaretzki A III. Thymectomy for myasthenia gravis: an analysis of the controversies regarding technique and results. Neurology 1997;48 Suppl 5:S52-63.
2. Jaretzki A III. Thymectomy for myasthenia gravis: analysis of controversies - patient management. The Neurologist 2003; 9:77-92.
3. Shrager JB, Deeb ME, Mick R, et al. Transcervical thymectomy for myasthenia gravis achieves results comparable to thymectomy by sternotomy. Ann Thorac Surg 2002;74:320-7.
4. Pego-Fernandes PM, deCampos JRM, Jatene FB, et al. Thymectomy by partial sternotomy for the treatment of myasthenia gravis. Ann Thorac Surg 2002;74:204-8.
5. deCampos JRM, Filomeno LTB, Marchiori PE, Jatene FB. Partial sternotomy approach to the thymus. In: Yim AP, Hazelrigg SR, Izzat B, Landreneau RJ, Mack MJ, Naunheim KS, eds. Minimal access cardiothoracic surgery. Philadelphia, PA: WB Saunders Co, 2000:205-8.
6. Papatestas AE, Genkins G, Kornfeld P. Comparison of the results of the transcervical and transternal thymectomy in myasthenia gravis. Ann NY Acad Sci 1981;377:766-78.
7. Oosterhuis HJ. Observations of the natural history of myasthenia gravis and the effect of thymectomy. Ann NY Acad Sci 1981;377:678-89.
8. Sanders DB, Kaminski HJ, Jaretzki A III, Phillips LH II. Thymectomy for myasthenia gravis in older patients. J Am Coll Surg 2001;193(3):340-1.
9. Kissel JT, Franklin GM. American Academy of Neurology Quality Standards Subcommittee. Treatment of myasthenia gravis: a call to arms. Neurology 2000;55:3-4.
10. Goodin DS, Frohman EM, Garmony GP, et al. Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines. Neurology 2002;58:169-77.
11. Wolfe GI, Kaminski HJ, Jaretzki A III, et al. Thymectomy trial in non-thymomatous myasthenia gravis patients receiving immunosuppressive therapy. Ann NY Acad Sci. In Press.
12. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000;342:1887-92.
13. Benson K, Hart AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000;342:1878-86.
14. Kirklin JW, Blackstone EH. Clinical studies with non-randomly assigned treatment. In: Kirklin JW, Barrett-Boyes BG, eds. Cardiac surgery. 2nd ed. New York: Churchill-Livingstone, 1993:269-70.
15. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Jaretzki A III, Barohn RB, et al. Myasthenia gravis: recommendations for clinical research standards. Ann Thorac Surg 2000;70:327-34.
16. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America, Jaretzki A III, Barohn RB, et al. Myasthenia gravis: recommendations for clinical research standards. Neurology 2000;55:16-23.
17. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Jaretzki A III, Barohn RB, et al. Myasthenia gravis: recommendations for clinical research standards. www.myasthenia.org/research/Clinical_Research_Standards.pdf. Accessed 2003 April 12.
18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
19. Weinberg A, Gelijns A, Moskowitz A, Jaretzki A. Myasthenia gravis: outcomes analysis. www.myasthenia.org/research/Clinical_Research_Standards.pdf. Accessed 2003 April 12. Reprints available via Myasthenia Gravis Foundation of America, Inc. 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416.
20. Heagerty PJ, Zeger SL. Marginal regression models for clustered ordinal measurements. J Am Stat Assoc 1996; 91(435):1024-36.
21. Jaretzki A III, Penn AS, Younger DS, et al. "Maximal" thymectomy for myasthenia gravis: results. J Thorac Cardiovasc Surg 1988;95:747-57.
22. Lindberg C, Andersen O, Larsson S, Oden A. Remission rate after thymectomy in myasthenia gravis when the bias of immunosuppressive therapy is eliminated. Acta Neurol Scand 1992;86(3):323-8.
23. Papatestas AE, Genkins G, Kornfield P, et al. Effects of thymectomy in myasthenia gravis. Ann Surg 1987;206(1):79-88.
24. Rodriguez M, Gomez MR, Howard F, Taylor WF. Myasthenia gravis in children: long term follow-up. Ann Neurol 1983;13:504-10.